Boehringer Sues Apotex To Protect Zantac Patent
Boehringer Ingelheim Pharmaceuticals Inc. is suing Apotex Inc., claiming the Canadian company's generic version of its over-the-counter heartburn treatment Zantac infringes a Boehringer patent....To view the full article, register now.
Already a subscriber? Click here to view full article